Mathew Blackman

Stock Analyst at TD Cowen

(4.41)
# 1,233
Out of 5,090 analysts
280
Total ratings
50.9%
Success rate
12.4%
Average return

Stocks Rated by Mathew Blackman

Alphatec Holdings
Oct 30, 2026
Reiterated: Buy
Price Target: $13 → $10
Current: $7.04
Upside: +42.05%
Stryker
Oct 30, 2026
Reiterated: Hold
Price Target: $298 → $290
Current: $291.86
Upside: -0.64%
Beta Bionics
Oct 28, 2026
Reiterated: Hold
Price Target: $18 → $21
Current: $16.75
Upside: +25.37%
OrthoPediatrics
Oct 28, 2026
Reiterated: Buy
Price Target: $23 → $28
Current: $30.87
Upside: -9.30%
Globus Medical
Aug 6, 2026
Reiterated: Buy
Price Target: $115
Current: $78.05
Upside: +47.34%
Insulet
Aug 6, 2026
Rated: Hold
Price Target: $294 → $144
Current: $149.68
Upside: -3.79%
Tandem Diabetes Care
Aug 6, 2026
Reiterated: Buy
Price Target: $28
Current: $19.11
Upside: +46.52%
Orthofix Medical
Aug 5, 2026
Reiterated: Hold
Price Target: $12
Current: $9.07
Upside: +32.30%
Zimmer Biomet Holdings
Aug 5, 2026
Reiterated: Buy
Price Target: $109 → $115
Current: $94.52
Upside: +21.67%
SI-BONE
Aug 4, 2026
Rated: Buy
Price Target: $18 → $20
Current: $21.23
Upside: -5.79%
Reiterated: Buy
Price Target: $485
Current: $432.01
Upside: +12.27%
Reiterated: Buy
Price Target: $25
Current: $10.67
Upside: n/a
Reiterated: Hold
Price Target: $10 → $7
Current: $6.86
Upside: n/a
Reiterated: Buy
Price Target: $100
Current: $82.29
Upside: n/a
Reiterated: Buy
Price Target: $301 → $318
Current: $318.95
Upside: n/a
Reiterated: Buy
Price Target: $50
Current: $9.51
Upside: n/a
Reiterated: Hold
Price Target: $10 → $11
Current: $5.81
Upside: n/a
Reiterated: Buy
Price Target: $3
Current: $2.28
Upside: n/a